Kate Farms Acquired by Danone, Marking New Chapter in Plant-Based Clinical Nutrition
Deal News | Jul 01, 2025 | PR Newswire Cision Novo Holdings
Kate Farms, a pioneer in plant-based, organic clinical nutrition, has been acquired by Danone, marking a significant milestone in the nutritive industry. With a focus on providing medically tailored nutrition, Kate Farms has seen tremendous growth, bolstered by major institutional support from Novo Holdings, which led its Series C financing with $75 million in 2022. The acquisition highlights Novo Holdings' strategic focus on investing in scalable, science-driven companies capable of driving systemic change within the food and nutrition sector. The deal integrates Kate Farms into Danone's North America Medical Nutrition division, enhancing its capacity to serve those with specialized health needs more effectively. Kate Farms will benefit from Danone's extensive resources, with Brett Matthews, current CEO, continuing to lead the business and expanding reach in the clinically supported nutrition marketplace.
Sectors
- Healthcare & Nutrition
- Investment Management
- Food & Beverage
Geography
- United States – Kate Farms is a US-based company and much of its operations and market are focused in the US.
- Europe – Novo Holdings, based in Denmark and part of the European market, represents significant European investment interests in the acquisition.
Industry
- Healthcare & Nutrition – The article focuses on Kate Farms, a provider of clinical nutrition, aligning with the healthcare and nutrition industry.
- Investment Management – Novo Holdings' investment and subsequent acquisition by Danone demonstrate key activities in investment management, including portfolio scaling and strategic exits.
- Food & Beverage – Danone's acquisition of Kate Farms highlights strategies in the food and beverage industry, particularly in health-enhancing and plant-based products.
Financials
- 75 million USD – The amount led by Novo Holdings in Kate Farms' Series C financing in September 2022.
- EUR 142 billion – Total assets of Novo Holdings as of year-end 2024.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Kate Farms | Target Company | Company | A US-based market leader in plant-based, clinical nutrition. |
| Danone | Bidding Companybuyer | Company | A global leader in food and nutrition acquiring Kate Farms. |
| Novo Holdings | Selling Company | Company | Major institutional investor in Kate Farms, leading its Series C funding. |
| Brett Matthews | CEO of Danone's North America Medical Nutrition | People | Current CEO of Kate Farms and future leader in Danone's division. |